<DOC>
	<DOCNO>NCT01368185</DOCNO>
	<brief_summary>This retrospective , chart review , observational study assess effect MK-0954A ( losartan potassium 50 mg + hydrochlorothiazide 12.5 mg [ Hyzaar ( R ) ] ) treatment period least three month serum uric acid level .</brief_summary>
	<brief_title>Impact MK-0954A Uric Acid Management Hypertension ( MK-0954A-366 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>Inclusion criterion : Participant &gt; 20 year &lt; 75 year age index date ( i.e. , date initiating MK0954A therapy ) Diagnosed hypertension receive MK0954A 50/12.5 mg least 3 month Had least one serum uric acid measurement baseline one 3 month use MK0954A 50/12.5 mg Had follow record document chart data collection period : medical history comorbidities ( available ) sit blood pressure , serum uric acid , lipid profile test result use MK0954A 50/12.5 mg serum electrolyte , serum creatinine , premeal sugar ( available ) prescription information antihypertensive regimen Exclusion criterion : Had treat diuretic angiotensinreceptor blocker ( ARBs ) 2 week initiate treatment MK0954A 50/12.5 mg Serum creatinine &gt; 2 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Essential hypertension Uric acid Retrospective Hyzaar</keyword>
</DOC>